In these studies, bystander CD8+ TILs were shown to lack CD39 expression [8], while tumor-specific T cells have been defined by expression of a variety markers including PD-1 [9], CD103 [10], CD39 [11] and CD137 [12]. This evidence concerns the gene CD8A and neoplasm.